David M. Berman - 04 Dec 2025 Form 4 Insider Report for Immunocore Holdings plc (IMCR)

Reporting relationship: HEAD OF R&D
Issuer ticker: IMCR
Reported as of: 04 Dec 2025
Net transaction value: -$727,548
SEC form: 4
Accepted by SEC: 08 Dec 2025, 16:15:14 UTC
Prior SEC filing: 01 Dec 2025
Next SEC filing: 19 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Lily Hepworth, Attorney-in-Fact

Key filing fact

David M. Berman filed Form 4 for Immunocore Holdings plc (IMCR) on 08 Dec 2025.

Key facts

This page summarizes David M. Berman's Form 4 filing for Immunocore Holdings plc (IMCR).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 08 Dec 2025, 16:15.

Change

Previous filing in this sequence was filed on 01 Dec 2025.
Current net transaction value: -$727,548.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001955244 Primary reporting owner

Berman David M

Relationship: HEAD OF R&D
Address: C/O IMMUNOCORE HOLDINGS PLC, 92 PARK DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, UNITED KINGDOM
Signature: /s/ Lily Hepworth, Attorney-in-Fact
Signature date: 08 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IMCR transaction

Ordinary Shares

Options Exercise

Transaction value: $547,214
Shares: +31,341
Change %
Price: $17.46
Shares after: 31,341
Date: 04 Dec 2025
Ownership: Direct
Footnotes: F1

IMCR transaction

Ordinary Shares

Sale

Transaction value: $1,261,789
Shares: -31,341
Change %: -100%
Price: $40.26
Shares after: 0
Date: 04 Dec 2025
Ownership: Direct
Footnotes: F1, F2

IMCR transaction

Ordinary Shares

Options Exercise

Transaction value: $9,987
Shares: +572
Change %
Price: $17.46
Shares after: 572
Date: 05 Dec 2025
Ownership: Direct
Footnotes: F1

IMCR transaction

Ordinary Shares

Sale

Transaction value: $22,960
Shares: -572
Change %: -100%
Price: $40.14
Shares after: 0
Date: 05 Dec 2025
Ownership: Direct
Footnotes: F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMCR transaction Derivative

Employee Share Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -31,341
Change %: -72%
Price: $0.000000
Shares after: 12,404
Date: 04 Dec 2025
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 31,341
Exercise price: $17.46
Footnotes: F1, F4

IMCR transaction Derivative

Employee Share Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -572
Change %: -4.6%
Price: $0.000000
Shares after: 11,832
Date: 05 Dec 2025
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 572
Exercise price: $17.46
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.02 to $40.44 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.21 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F4

Immediately exercisable.